(19)
(11) EP 4 577 297 A2

(12)

(88) Date of publication A3:
18.04.2024

(43) Date of publication:
02.07.2025 Bulletin 2025/27

(21) Application number: 23858188.8

(22) Date of filing: 18.08.2023
(51) International Patent Classification (IPC): 
A61N 1/36(2006.01)
A61N 1/05(2006.01)
A61N 1/04(2006.01)
(52) Cooperative Patent Classification (CPC):
A61N 1/3605; A61N 1/36062; A61N 1/36053
(86) International application number:
PCT/US2023/072507
(87) International publication number:
WO 2024/044515 (29.02.2024 Gazette 2024/09)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 25.08.2022 US 202263373536 P

(71) Applicants:
  • Boomerang Medical, Inc.
    Mountain View, CA 94040 (US)
  • Medtronic, Inc.
    Minneapolis MN 55432-5604 (US)

(72) Inventors:
  • MORRISS, John
    Mountain View, California 94040 (US)
  • MILLER, David
    Minneapolis, Minnesota 55432-5604 (US)

(74) Representative: Mewburn Ellis LLP 
Aurora Building Counterslip
Bristol BS1 6BX
Bristol BS1 6BX (GB)

   


(54) SYSTEMS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE USING NEUROMODULATION